Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin plus Xeloda in advanced liver cancer
NCT02013830Phase 2Completed
- Sponsor
- Roche
- Start
- May 2005
- Primary completion
- Mar 2008
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 2 trial of bevacizumab in liver cancer, sponsored by Roche. Started May 2005; status: completed.
02
Drugs
bevacizumab
03
Conditions
liver cancer
Beyond the preview
Go deeper on NCT02013830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02013830.